Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. (Q37276644)
Jump to navigation
Jump to search
scientific article published on 14 October 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. |
scientific article published on 14 October 2013 |
Statements
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans (English)
Shimon Sakaguchi
Hiroyoshi Nishikawa
Yuka Maeda
Megumi Nishioka
Atsushi Tanemura
Ichiro Katayama
Sachiko Ezoe
Yuzuru Kanakura
Eiichi Sato
Yasuo Fukumori
Julia Karbach
Elke Jäger
14 October 2013
17945-17950
1 reference
1 reference
1 reference
1 reference